Mochida Pharmaceutical Co., Ltd. (TYO:4534)
Japan
· Delayed Price · Currency is JPY 3,675.00
+45.00 (1.24%)
Mar 10, 2026, 9:46 AM JST
Mochida Pharmaceutical Cash Flow Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Net Income | - | 8,052 | 6,160 | 9,044 | 14,591 | 11,900 | Upgrade
|
| Depreciation & Amortization | - | 2,940 | 2,808 | 2,672 | 2,689 | 2,742 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | 14 | -22 | 53 | 112 | 107 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | - | -100 | - | -526 | - | Upgrade
|
| Loss (Gain) on Equity Investments | - | 618 | 168 | - | - | - | Upgrade
|
| Other Operating Activities | - | -951 | -1,366 | -4,172 | -5,709 | -2,121 | Upgrade
|
| Change in Accounts Receivable | - | 3,220 | -7,032 | 3,869 | -2,486 | -740 | Upgrade
|
| Change in Inventory | - | -3,016 | -5,873 | -1,277 | -521 | 2,466 | Upgrade
|
| Change in Accounts Payable | - | -3,522 | 2,225 | -1,941 | 2,176 | -3,934 | Upgrade
|
| Change in Other Net Operating Assets | - | 1,999 | -4,448 | -951 | -2,867 | -1,222 | Upgrade
|
| Operating Cash Flow | - | 9,354 | -7,480 | 7,297 | 7,459 | 9,198 | Upgrade
|
| Operating Cash Flow Growth | - | - | - | -2.17% | -18.91% | -1.59% | Upgrade
|
| Capital Expenditures | - | -2,160 | -2,296 | -2,166 | -2,988 | -1,935 | Upgrade
|
| Sale of Property, Plant & Equipment | - | 2 | 56 | - | - | 204 | Upgrade
|
| Investment in Securities | - | 19,500 | 2,301 | -1,100 | 1,098 | 1,000 | Upgrade
|
| Other Investing Activities | - | 13 | 13 | 317 | -117 | -149 | Upgrade
|
| Investing Cash Flow | - | 17,355 | 74 | -2,949 | -2,007 | -880 | Upgrade
|
| Repurchase of Common Stock | - | -3 | -3,492 | -3,512 | -2,511 | -2,008 | Upgrade
|
| Common Dividends Paid | - | -2,835 | -2,887 | -3,372 | -3,445 | -3,103 | Upgrade
|
| Other Financing Activities | - | -27 | -14 | - | - | -1 | Upgrade
|
| Financing Cash Flow | - | -2,865 | -6,393 | -6,884 | -5,956 | -5,112 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | 16 | 79 | 32 | 31 | -9 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | - | - | - | 1 | -2 | Upgrade
|
| Net Cash Flow | - | 23,860 | -13,720 | -2,504 | -472 | 3,195 | Upgrade
|
| Free Cash Flow | - | 7,194 | -9,776 | 5,131 | 4,471 | 7,263 | Upgrade
|
| Free Cash Flow Growth | - | - | - | 14.76% | -38.44% | -1.70% | Upgrade
|
| Free Cash Flow Margin | - | 6.84% | -9.50% | 4.97% | 4.06% | 7.05% | Upgrade
|
| Free Cash Flow Per Share | - | 202.93 | -272.59 | 138.08 | 117.34 | 188.00 | Upgrade
|
| Cash Interest Paid | - | 18 | 37 | 35 | 36 | 36 | Upgrade
|
| Cash Income Tax Paid | - | 948 | 1,368 | 3,224 | 3,616 | 2,154 | Upgrade
|
| Levered Free Cash Flow | - | 6,041 | -10,050 | 5,890 | 5,615 | 8,755 | Upgrade
|
| Unlevered Free Cash Flow | - | 6,042 | -10,049 | 5,890 | 5,615 | 8,755 | Upgrade
|
| Change in Working Capital | - | -1,319 | -15,128 | -300 | -3,698 | -3,430 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.